Organon NV

Type
Internal restructuring
Country
Netherlands
Region
Zuid-Nederland; Noord-Brabant; Noordoost-Noord-Brabant
Location of affected unit(s)
Oss
Sector
Manufacturing
(20 - 21) Manufacture of chemicals and pharmaceuticals
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
150 - 210 jobs
Number of planned job losses
Job loss
Announcement Date
10 March 2003
Employment effect (start)
Foreseen end date

Description

Organon has developed innovative prescription medicines for gynecology, mental health, anesthesia, and for cardiovascular diseases. The company currently employs around 13,000 people in more than 50 countries. Worlwide, Akzo Nobel decided to suppress some 500 jobs. The management will use early retirements and other ways to avoid direct dismissals. In April 2003, 60 more jobs suppressed in Oss.

Sources

  • 2 April 2003: De Financiële Telegraaf

Citation

Eurofound (2003), Organon NV, Internal restructuring in Netherlands, factsheet number 58840, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/58840.